Heron Therapeutics | HRTX - Trade Debtors

Stock Price
1.06
Daily Change
-0.07 -6.19%
Monthly
-12.40%
Yearly
-55.83%
Q1 Forecast
1.15

Heron Therapeutics reported $67.04M in Trade Debtors for its fiscal quarter ending in September of 2024.





Trade Debtors Change Date
ALKERMES USD 334.02M 21.08M Dec/2025
Alnylam Pharmaceuticals USD 777.57M 187.2M Dec/2025
Amarin USD 127.31M 8.18M Sep/2025
ANI Pharmaceuticals USD 281.08M 28.46M Dec/2025
Anika Therapeutics USD 21.99M 1.61M Mar/2025
Arrowhead Research USD 218.87M 212.05M Dec/2025
Eisai JPY 249.06B 25B Dec/2025
Emergent BioSolutions USD 290.1M 134.2M Jun/2023
Esperion Therapeutics USD 60.36M 5.75M Jun/2024
GlaxoSmithKline GBP 7.76B 545M Dec/2025
Heron Therapeutics USD 67.04M 6.9M Sep/2024
Insmed USD 140.86M 75.6M Dec/2025
Ligand Pharmaceuticals USD 58.1M 15.98M Sep/2025
Merck USD 12.12B 596M Sep/2025
Nektar Therapeutics USD 0 2.9M Sep/2024
Neurocrine Biosciences USD 686.8M 41.2M Dec/2025
Omeros USD 8.08M 440K Jun/2024
Pacira USD 124.07M 8.8M Dec/2025
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Roche Holding CHF 11.9B 460M Dec/2025
Sangamo BioSciences USD 581K 110K Jun/2024
Surmodics USD 23.27M 790K Sep/2024
Ultragenyx Pharmaceutical USD 112.54M 11.92M Sep/2025
Veracyte USD 44.66M 3.17M Dec/2025
Vertex Pharmaceuticals USD 2.05B 106.4M Dec/2025